Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Blazevic RL"'
Autor:
Lim FY; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Chemistry., Kim SY; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Kulkarni KN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Blazevic RL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Kimball LE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Lea HG; Department of Chemistry., Haack AJ; Department of Chemistry., Gower MS; Department of Chemistry., Stevens-Ayers T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Starita LM; Brotman Baty Institute.; Department of Genome Sciences., Boeckh M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine., Hyrien O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Schiffer JT; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine., Theberge AB; Department of Chemistry.; Department of Urology, and., Waghmare A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Pediatrics, University of Washington, Seattle, Washington, USA.; Seattle Children's Research Institute, Seattle, Washington, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2023 Dec 01; Vol. 133 (23). Date of Electronic Publication: 2023 Dec 01.
Autor:
Kampouri E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Zamora D; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA., Kiem ES; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Liu W; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Ibrahimi S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Blazevic RL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Lovas EA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Kimball LE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Huang ML; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Jerome KR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Ueda Oshima M; Department of Medicine, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Mielcarek M; Department of Medicine, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Zerr DM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Pediatrics, University of Washington, Seattle, WA, USA., Boeckh MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Krantz EM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Hill JA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. Electronic address: Jahill3@fredhutch.org.
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2023 Nov; Vol. 29 (11), pp. 1450.e1-1450.e7. Date of Electronic Publication: 2023 Jul 31.
Autor:
Doll MK; Department of Population Health Sciences, Albany College of Pharmacy & Health Sciences, Albany, New York., Waghmare A; Division of Infectious Diseases, Department of Pediatrics, University of Washington, Seattle.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington., Heit A; Amazon, Seattle, Washington., Levenson Shakoor B; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California., Kimball LE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington., Ozbek N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington., Blazevic RL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington., Mose L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington., Boonyaratanakornkit J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington., Stevens-Ayers TL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington., Cornell K; St Luke's Medical Center, Ketchum, Idaho., Sheppard BD; St Luke's Medical Center, Ketchum, Idaho., Hampson E; St Luke's Medical Center, Ketchum, Idaho., Sharmin F; Department of Population Health Sciences, Albany College of Pharmacy & Health Sciences, Albany, New York., Goodwin B; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California., Dan JM; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California.; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla., Archie T; St Luke's Medical Center, Ketchum, Idaho., O'Connor T; St Luke's Medical Center, Ketchum, Idaho.; Department of Emergency Medicine, University of Washington, Seattle., Heckerman D; Amazon, Seattle, Washington., Schmitz F; Amazon, Seattle, Washington., Boeckh M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle., Crotty S; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California.; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla.
Publikováno v:
JAMA network open [JAMA Netw Open] 2023 Feb 01; Vol. 6 (2), pp. e231181. Date of Electronic Publication: 2023 Feb 01.
Autor:
Lim FY; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, Washington, U.S.A.; Department of Chemistry, University of Washington; Seattle, Washington, U.S.A., Kim SY; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, Washington, U.S.A., Kulkarni KN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, Washington, U.S.A., Blazevic RL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, Washington, U.S.A., Kimball LE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, Washington, U.S.A., Lea HG; Department of Chemistry, University of Washington; Seattle, Washington, U.S.A., Haack AJ; Department of Chemistry, University of Washington; Seattle, Washington, U.S.A., Gower MS; Department of Chemistry, University of Washington; Seattle, Washington, U.S.A., Stevens-Ayers T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, Washington, U.S.A., Starita LM; Brotman Baty Institute, University of Washington, Seattle.; Department of Genome Sciences, University of Washington, Seattle., Boeckh M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, Washington, U.S.A.; Department of Medicine, University of Washington; Seattle, Washington, U.S.A., Schiffer JT; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, Washington, U.S.A.; Department of Medicine, University of Washington; Seattle, Washington, U.S.A., Hyrien O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, Washington, U.S.A., Theberge AB; Department of Chemistry, University of Washington; Seattle, Washington, U.S.A.; Department of Urology, University of Washington; Seattle, Washington, U.S.A., Waghmare A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, Washington, U.S.A.; Department of Pediatrics, University of Washington; Seattle, Washington, U.S.A.; Seattle Children's Research Institute; Seattle, Washington, U.S.A.
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2023 Jan 28. Date of Electronic Publication: 2023 Jan 28.
Autor:
Doll MK; Department of Population Health Sciences, Albany College of Pharmacy & Health Sciences, Albany, NY, USA., Waghmare A; Division of Infectious Diseases, Department of Pediatrics, University of Washington, Seattle, WA, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Heit A; Amazon, Inc., Seattle, WA, USA., Levenson Shakoor B; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA., Kimball LE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Ozbek N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Blazevic RL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Mose L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Boonyaratanakornkit J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Stevens-Ayers TL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Cornell K; St. Luke's Medical Center, Ketchum, ID, USA., Sheppard BD; St. Luke's Medical Center, Ketchum, ID, USA., Hampson E; St. Luke's Medical Center, Ketchum, ID, USA., Sharmin F; Department of Population Health Sciences, Albany College of Pharmacy & Health Sciences, Albany, NY, USA., Goodwin B; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA., Dan JM; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, California, USA., Archie T; St. Luke's Medical Center, Ketchum, ID, USA., O'Connor T; St. Luke's Medical Center, Ketchum, ID, USA.; Department of Emergency Medicine, University of Washington, Seattle, WA, USA., Heckerman D; Amazon, Inc., Seattle, WA, USA., Schmitz F; Amazon, Inc., Seattle, WA, USA., Boeckh M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA., Crotty S; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, California, USA.
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2022 Nov 14. Date of Electronic Publication: 2022 Nov 14.